Directory
>
Peg Crowley-Nowick
Peg Crowley-Nowick
President, Medical Affairs Consulting, Head of Medical Affairs | Lumanity
Marion, Massachusetts, United States
Peg Crowley-Nowick
Summary
Dr. Peg Crowley-Nowick is a distinguished leader in the pharmaceutical and medical affairs sectors, with nearly 25 years of experience in clinical research and drug development. Currently serving as President at Lumanity Medical Affairs Consulting, she spearheads integrated services for medical affairs, demonstrating her expertise in navigating complex product launches across various therapeutic areas including oncology and cardiovascular health. Dr. Crowley-Nowick has a strong academic foundation, having held assistant professorships at both Harvard Medical School and the University of Pittsburgh School of Medicine. Her career is marked by a commitment to patient-centric care and collaborative strategies that drive innovation in medical affairs. With a PhD in Immunology and a BS in Microbiology, she combines scientific rigor with strategic insight. Dr. Crowley-Nowick's influence extends beyond her roles, as she actively contributes to advisory boards and educational initiatives in the life sciences.
Peg Crowley-Nowick
Work Experience
President, Medical Affairs Consulting, Head of Medical Affairs at
Lumanity
January 2023 - Present
Chair, Integrated Concentration in Science (iCons) Advisory Board at
University of Massachusetts Amherst
March 2021 - Present
Member & Past Co-Chair Deans Advisory Board College of Natural Sciences at
University of Massachusetts Amherst
April 2013 - Present
President at
Zipher Medical Affairs Co Llc A Lumanity Business
November 2008 - January 2023
Head, Global Publications and Communications Oncology at
Bayer AG
January 2007 - January 2008
Medical Director, Oncology at
Berlex Laboratories
April 2005 - August 2007
Manager, Oncology at
Berlex Laboratories
January 2003 - January 2005
Medical Science Liaison at
Berlex Laboratories
January 2002 - January 2003
Assistant Professor at
Harvard University
January 1997 - January 2002
Assistant Professor at
University of Pittsburgh
January 1993 - January 1997
Peg Crowley-Nowick
Education
University Of Alabama School Of Medicine, Phd
January 1986 - January 1991
University of Massachusetts Amherst, Bs
January 1982 - January 1986
Frequently Asked Questions about Peg Crowley-Nowick
What company does Peg Crowley-Nowick work for?
Peg Crowley-Nowick is a President, Medical Affairs Consulting, Head of Medical Affairs at Lumanity, a company specializing in Business consulting, nec.
Where Peg Crowley-Nowick graduated from?
Peg Crowley-Nowick holds a degree in Immunology from University Of Alabama School Of Medicine.
Who is Peg Crowley-Nowick?
Dr. Peg Crowley-Nowick is a distinguished leader in the pharmaceutical and medical affairs sectors, with nearly 25 years of experience in clinical research and drug development. Currently serving as President at Lumanity Medical Affairs Consulting, she spearheads integrated services for medical affairs, demonstrating her expertise in navigating complex product launches across various therapeutic areas including oncology and cardiovascular health. Dr. Crowley-Nowick has a strong academic foundation, having held assistant professorships at both Harvard Medical School and the University of Pittsburgh School of Medicine. Her career is marked by a commitment to patient-centric care and collaborative strategies that drive innovation in medical affairs. With a PhD in Immunology and a BS in Microbiology, she combines scientific rigor with strategic insight. Dr. Crowley-Nowick's influence extends beyond her roles, as she actively contributes to advisory boards and educational initiatives in the life sciences.
Peg`s contact details
Colleagues
Vice President, Client Solutions
Chief Marketing Officer
Vice President, Life Science Solutions
Global President, Market Access
Global President, Market Access
President, Insight USA
Chief Commercial and Development Officer
SVP, Medical Services, US Communications
Chief Operating Officer and Global Practice Leader - Value, Access and Outcomes
Vice President Evidence Evaluation Technical Strategy